Genetics/Genomics News

Lipids, hypertension, lipoprotein(a), inflammation, atherogenesis and diet are some of the many topics that will be covered at this year’s American Society for Preventive Cardiology Congress on CVD Prevention.

Triglycerides in LDL predicted CVD events and were associated with a genetic variant, according to new findings.

The American Society for Preventive Cardiology 2018 Congress on CVD Prevention, running from July 27 to 29, will provide attendees with a look at new advancements in CVD prevention, management and treatment.

After a panel examined the clinical validity of 21 genes believed to be associated with causing Brugada syndrome, it deemed only one to be definitive evidence.

Across all genetic risk groups, poor lifestyle was associated with elevated risk for adverse CV outcomes, according to a new analysis.

A reduction of lipoprotein(a) and an absolute reduction in Lp(a) concentration had a proportional clinical benefit, according to an analysis published in JAMA Cardiology.

Genomic medicine can potentially be used to predict a patient’s risk for heart disease and the course it may follow, as well as to determine what medications would be best suited for them, according to an American Heart Association scientific advisory published in Circulation: Genomic and Precision Medicine.

Researchers have identified causal genes and genetic variants associated with chromosomal regions connected with atrial fibrillation risk.

LAS VEGAS — Patients with familial chylomicronemia syndrome who were connected actively or passively through a support group had improved disease outlook, perception of overall health and emotional well-being compared with those who were disconnected, according to data presented at the National Lipid Association Scientific Sessions.

LAS VEGAS — Early initiation of statin therapy may reduce CV risk in children with familial hypercholesterolemia, according to a presentation at National Lipid Association Scientific Sessions.